» Articles » PMID: 22009222

Recurrent Trisomy and Robertsonian Translocation of Chromosome 14 in Murine IPS Cell Lines

Overview
Journal Chromosome Res
Date 2011 Oct 20
PMID 22009222
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Induced pluripotent stem (iPS) cells have greatly provoked people's interest due to their enormous potential of clinical applications. Increasing care is taken with the genetic safety of iPS cells. However, up to now, the chromosomal integrity of murine iPS (miPS) cells has been largely unknown. We have observed recurrent trisomy and/or Robertsonian translocation (Rb) of chromosome 14 in six out of nine independent miPS cell lines from three laboratories by G-banding, fluorescence in situ hybridization (FISH) and spectral karyotyping (SKY) analyses, while all the miPS cell lines were derived from mouse embryonic fibroblasts (MEFs) or neural precursor cells (NPCs) with a normal karyotype. The miPS cells with trisomy and/or Rb of chromosome 14 showed growth advantage over the miPS cells with a normal karyotype. We found a significantly higher frequency of Rbs in the miPS cell lines induced with c-Myc than those without c-Myc. Our findings demonstrate that miPS cell lines have the propensity for chromosomal aberrations and there is an obvious correlation between the extent of chromosomal aberrations in miPS cells and the transcriptional factors used for their reprogramming. Therefore, our study raises awareness of the need for improvements of the induction conditions of miPS cells in order to avoid the chromosomal aberrations and ensure future safe applications.

Citing Articles

Chromosomal aberration arises during somatic reprogramming to pluripotent stem cells.

Liu X, Li C, Zheng K, Zhao X, Xu X, Yang A Cell Div. 2020; 15(1):12.

PMID: 33292330 PMC: 7641821. DOI: 10.1186/s13008-020-00068-z.


Achilles' heel of pluripotent stem cells: genetic, genomic and epigenetic variations during prolonged culture.

Rebuzzini P, Zuccotti M, Redi C, Garagna S Cell Mol Life Sci. 2016; 73(13):2453-66.

PMID: 26961132 PMC: 11108315. DOI: 10.1007/s00018-016-2171-8.


SIRT1 is necessary for proficient telomere elongation and genomic stability of induced pluripotent stem cells.

De Bonis M, Ortega S, Blasco M Stem Cell Reports. 2014; 2(5):690-706.

PMID: 24936455 PMC: 4050480. DOI: 10.1016/j.stemcr.2014.03.002.


c-MYC-induced genomic instability.

Kuzyk A, Mai S Cold Spring Harb Perspect Med. 2014; 4(4):a014373.

PMID: 24692190 PMC: 3968784. DOI: 10.1101/cshperspect.a014373.


Preclinical studies for induced pluripotent stem cell-based therapeutics.

Harding J, Mirochnitchenko O J Biol Chem. 2013; 289(8):4585-93.

PMID: 24362021 PMC: 3931020. DOI: 10.1074/jbc.R113.463737.


References
1.
Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

2.
Korenberg J, Chen X, Devon K, Noya D, Birren B . Mouse molecular cytogenetic resource: 157 BACs link the chromosomal and genetic maps. Genome Res. 1999; 9(5):514-23. PMC: 310771. View

3.
Mayshar Y, Ben-David U, Lavon N, Biancotti J, Yakir B, Clark A . Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell. 2010; 7(4):521-31. DOI: 10.1016/j.stem.2010.07.017. View

4.
Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T . Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2007; 26(1):101-6. DOI: 10.1038/nbt1374. View

5.
Liyanage M, Weaver Z, Barlow C, Coleman A, Pankratz D, Anderson S . Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice. Blood. 2000; 96(5):1940-6. View